Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis - VIVA

Description:

The goal of the Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis (VIVA) trial was to evaluate the safety and efficacy of intracoronary (IC) and intravenous (IV) infusions of recombinant human vascular endothelial growth factor protein (rhVEGF) in patients with chronic myocardial ischemia unsuitable for standard revascularization.